FierceBiotech Feb 11, 2026 Upstream posts Tezspire-like asthma efficacy in phase 2 but falls short of best-case scenario
FierceBiotech Feb 11, 2026 Madrigal pens $4.4B deal for Ribo's preclinical siRNA programs in latest Rezdiffra MASH play
Thermo Fisher Feb 11, 2026 Thermo Fisher, Datavant to Partner on Linking Real-World Data to Clinical Research - Contract Pharma
Thermo Fisher Feb 11, 2026 Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish? - Barchart.com
Thermo Fisher Feb 11, 2026 Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish? - Yahoo Finance
Thermo Fisher Feb 11, 2026 Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish? - FinancialContent
Agilent Feb 11, 2026 Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - BioSpace
Endpoints News Feb 11, 2026 How a closet full of EKG machines illustrates pharma’s clinical trial cost problem
Endpoints News Feb 11, 2026 Post-Hoc Live: Is biotech’s relationship with the FDA at a breaking point?
Thermo Fisher Feb 11, 2026 Insiders At Thermo Fisher Scientific Sold US$3.6m In Stock, Alluding To Potential Weakness - Yahoo Finance